Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities

BMC Infectious Diseases

Naeem Akhtar¹  Shujaat Ali Khan²  Abdul Mannan²  Saira Iram³  Muhammad Arfat Yameen³ 

[1] Department of Microbiology, University of Health Sciences, Lahore, 54600, Pakistan;Department of Pharmaceutical Sciences, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan;Microbiology Research Laboratory, Department of Microbiology, Quaid-I-Azam University, Islamabad 45320, Pakistan

关键词: Vancomycin resistant enterococci;    Antimicrobial susceptibility;    Enterococci colonization;   

Others  :  1149099
DOI  :  10.1186/1471-2334-13-156

 received in 2012-07-10, accepted in 2013-03-15,  发布年份 2013

【 摘 要 】

Background

Enterococci normally inhabit the intestinal tract of humans and are also a potential pathogen in causing nosocomial infections. The increase in antibiotic resistance and transfer of antibiotic resistance gene to Staphylococcus aureus (S. aureus) due to co-colonization has increased its importance in research. The aim of the study was to evaluate local epidemiology of nasal and rectal colonization with Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) in patients of Paediatrics Intensive Care Unit (PICU) and correlation with clinical and socioeconomic factors.

Methods

The nasal and perirectal swab samples were collected from 110 patients admitted in PICUs of three tertiary care hospitals of Rawalpindi Medical College, Pakistan. The identification of enterococci was done by biochemical tests and by PCR for ddl, vanA and vanB genes. Antibiotic susceptibility testing was performed by disc diffusion and MICs were determined for vancomycin, tetracycline, ciprofloxacin and oxacillin only.

Results

Out of 220 nasal and perirectal samples, 09 vancomycin-resistant enterococci (VRE) and 76 vancomycin-susceptible enterococci (VSE), consisting of 40 E. faecalis and 45 E. faecium were isolated. PCR successfully identified both species with ddl primers and VRE with vanA primer. With disc diffusion method, all isolates were resistant to most of the antibiotics tested except linezolid, quinupristin/dalfopristin, teicoplanin and vancomycin. VRE showed resistance to teicoplanin and vancomycin both and none was resistant to linezolid and quinupristin/dalfopristin. Generally, E. faecium isolates were more resistant than E. faecalis. MICs of vancomycin for nasal and perirectal VRE were 512 mg/L and 64 to 512 mg/L respectively. VRE were more in patients with prolonged hospitalization, from urban localities and those having pneumonia.

Conclusion

Present study reveals high colonization and antibiotic resistance in enterococcal isolates from nasal and perirectal area. Nasal colonization by enterococci in PICU is more alarming as VRE may cause infection and can transfer this resistance gene to other microorganisms like S. aureus.

【 授权许可】

   
2013 Yameen et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Facklam RR, Sahm DF, Teixeira LM: Enterococcus. In Manual of clinical microbiology. 7th edition. Edited by Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH. Washington, D.C: ASM Press; 1999:297-305.
• [2]Facklam RR, Sahm DF: Enterococcus. In Manual of clinical microbiology. 6th edition. Edited by Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH. Washington, DC: ASM Press; 1995:308-314.
• [3]Moellering RC: Vancomycin-resistant enterococci. Clin Infect Dis 1998, 26:1196-1199.
• [4]Spera RV, Farber BF: Multiply-resistant Enterococcus-faecium - the nosocomial pathogen of the 1990s. JAMA 1992, 268:2563-2564.
• [5]Emori TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993, 6:428-442.
• [6]National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997. A report from the NNIS System. American Journal of Infection Control 1997, 25:477-487.
• [7]Chenoweth CE, Schaberg DR: Enerococcus species. In Hospital epidemiology and infection control. Edited by Mayhall CG. Baltimore: Williams & Wilkins; 1996:334-345.
• [8]Noble WC, Virani Z, Cree RG: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992, 72:195-198.
• [9]Showsh SA, De Boever EH, Clewell DB: Vancomycin resistance plasmid in Enterococcus faecalis that encodes sensitivity to a sex pheromone also produced by Staphylococcus aureus. Antimicrob Agents Chemother 2001, 45:2177-2178.
• [10]Tiwari HK, Sen MR: Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 2006, 6:156. BioMed Central Full Text
• [11]Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR: The human nasal microbiota and Staphylococcus aureus carriage. PLoS One 2010, 5:15.
• [12]Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H: Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 2000, 38:3092-3095.
• [13]Louie L, Goodfellow J, Mathieu P, Glatt A, Louie M, Simor AE: Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol 2002, 40:2786-2790.
• [14]Mulder RH, Farnham SM, Grinius B: Evaluating antimicrobial susceptibility test systems. In Clinical microbiology procedures handbook. Edited by Isenberg H. Washington DC: ASM Press; 1995:1-14.
• [15]Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard. 8th edition. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2009.
• [16]Andrews JM, BSAC Working Party on Susceptibility Testing: BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009, 64:454-489.
• [17]Rathnayake IU, Hargreaves M, Huygens F: Genotyping of Enterococcus faecalis and Enterococcus faecium isolates by use of a set of eight single nucleotide polymorphisms. J Clin Microbiol 2011, 49:367-372.
• [18]Nannin EC, Murray BE: Enterococcus spp. In Principles and practice of clinical bacteriology. 2nd edition. Edited by Gillespie SH, Hawkey PM. West Sussex, UK: John Wiley & Sons; 2006:59-71.
• [19]Teixeira LM, Carvalho MDGS, Facklam RR: Enterococcus. In Manual of clinical microbiology. 9th edition. Edited by Murray PR. Washington D.C: ASM Press; 2007:430-442.
• [20]Sweet RL, Gibbs RS: Infectious diseases of the female genital tract. 5th edition. Philadelphia, PA: Lippincott Williams & Williams; 2009:480.
• [21]Harwood VJ, Delahoya NC, Ulrich RM, Kramer MF, Whitlock JE, Garey JR, Lim DV: Molecular confirmation of Enterococcus faecalis and E. faecium from clinical, faecal and environmental sources. Letters in applied microbiology 2004, 38:476-482.
• [22]Karimi A, Navidinia M, Tabatabaii SR, Fallah F, Malekan M, Jahromy H, Ahsani RR, Shiva F: The prevalence of vancomycin resistance genes in enterococci isolated from the stool of hospitalized patients in Mofid children hospital. Gene Therapy And Molecular Biology 2009, 13:294-300.
• [23]Burger H, Muller HE: Rhodococcus isolated from a gluteal abscess. Infection 1982, 10:343-346.
• [24]Weinstein JW, Tallapragada S, Farrel P, Dembry LM: Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. J Clin Microbiol 2002, 40:210-212.
• [25]Murray BE: Diversity among multidrug-resistant enterococci. Emerg Infect Dis 1998, 4:37-47.
• [26]Dutka-Malen S, Evers S, Courvalin P: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995, 33:1434.
• [27]Gold HS: Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis 2001, 33:210-219.
• [28]Caballero-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, Villanueva JL, Perez-Cano R, Pasquau J, Merino D, Menchero A, Mora D, Lopez-Ruz MA, Vergara A: Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. Journal of Clinical Microbiology 1998, 36:520-525.
• [29]Aleyasin A, Mobarez AM, Sadeghizadeh M, Doust RH, Khoramabadi N: Resistance to vancomycin in Enterococcus faecium and faecalis clinical isolates. Pakistan Journal of Medical Sciences 2007, 23:4-7.
• [30]Kowalska-Krochmal B, Dworniczek E, Dolna I, Seniuk A, Bania J, Walecka E, Wrzyszcz E: Antibiotic susceptibility levels of clinical Enterococcus spp. Strains, including those resistant to glycopeptides and high concentrations of aminoglycosides. Advances in Clinical and Experimental Medicine 2010, 19:155-162.
• [31]Cotter G, Adley CC: Ciprofloxacin susceptibility testing of enterococcal urinary isolates in accordance with BSAC guidelines. J Antimicrob Chemother 2001, 48:324-325.
• [32]Oberoi L, Aggarwal A: Multidrug resistant enterococci in a rural tertiary care hospital-a cause of concern. JK Science: Journal of Medical Education & 2010, 12:157-158.
• [33]Berk SL, Verghese A: Emerging pathogens in nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1989, 8:11-14.
• [34]Grupper M, Kravtsov A, Potasman I: Enterococcal-associated lower respiratory tract infections: a case report and literature review. Infection 2009, 37:60-64.
• [35]Berk SL, Verghese A, Holtsclaw SA, Smith JK: Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. The American journal of medicine 1983, 74:153-154.
• [36]Carmeli Y, Eliopoulos GM, Samore MH: Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002, 8:802-807.
• [37]Nahum E, Samra Z, Ben-Ari J, Dagan O, Schonfeld T, Ashkenazi S: Fecal Emergence of Vancomycin-Resistant Enterococci after Prophylactic Intravenous Vancomycin. The Internet Journal of Infectious Diseases 2002, 2:19.